Yoshimi Ohyabu
National Institute of Advanced Industrial Science and Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoshimi Ohyabu.
Journal of Orthopaedic Research | 2008
Ying Jiang; Hajime Mishima; Shinsuke Sakai; Liu Y; Yoshimi Ohyabu; Toshimasa Uemura
Adult bone marrow cells (BMCs) include two populations:;mesenchymal stem cells (MSCs), which can differentiate into bone, cartilage, and fat; and hematopoietic stem cells (HSCs), which produce all mature blood lineage. To study the effect of aging, gender, and age‐related disorders on lineage differentiation, we performed quantitative RT‐PCR to examine mRNA expression of the major factors defining BMC lineage, cbfa1 for osteoblasts, ppar‐gamma for adipocytes, sox9 for chondrocytes, and rankl for osteoclasts, in bone marrow from 80 healthy subjects and patients (14–79 years old) with two age‐related disorders: osteoarthritis (OA) and rheumatoid arthritis (RA). Two apoptosis‐related genes, bcl‐2 and drak1, were studied. RANKL and PPAR‐Gamma levels exhibited a clear positive correlation with age in female patients, but not in males, with a slight age‐related decline in CBFa1 transcripts. DRAK1 expression showed an age‐associated ascending trend with significantly greater transcripts of RANKL and DRAK1 in females (p < 0.01). Compared with age‐matched controls, RA patients exhibited increased RANKL, PPAR‐Gamma, and DRAK1 mRNA levels (p < 0.05), and OA showed the higher RANKL and PPAR‐Gamma transcripts (p < 0.05). Furthermore, SOX9 and DRAK1 expressions in the RA group were higher than in the OA group (p < 0.05). Our data indicate that aging and age‐related disorders affect gene expressions differently, suggesting that in aging, the lineage of bone marrow cells was modified with prominent changes in decreased bone marrow osteoblastogenesis, increased adipogenesis and osteoclastogenesis, while in age‐related disorders, marrow adipogenesis and the activity or number of osteoclasts may play an important role in the pathogenesis of arthritic bone loss.
Japanese Journal of Applied Physics | 2005
Shinobu Nomura; Hiroko Kojima; Yoshimi Ohyabu; Kosuke Kuwabara; Akihiro Miyauchi; Toshimasa Uemura
This is the first report of the successful culturing of HeLa cells on nanopillar sheets–a new type of cell culture dish–in a different way from that on flat petri dishes. Nanopillar sheets were fabricated with a high-aspect ratio structure with a diameter of 80–1000 nm and a height of 1–3 µm using nanoprint technology. Nanopillar structure with 500 nm diameter and 1 µm height enabled easy subculture of the cells from the sheets without the conventional trypsinization method. Moreover, the HeLa cells divided and proliferated on the sheets in the same way as on the flat surfaces with different manner of adhesion.
Journal of Artificial Organs | 2006
Shinobu Nomura; Hiroko Kojima; Yoshimi Ohyabu; Kosuke Kuwabara; Akihiro Miyauchi; Toshimasa Uemura
Nanopillar sheets were fabricated with high-aspect ratio structures with a diameter of 160–1000 nm and a height of 1 μm by nanoimprinting. The suitability of nanopillar sheets as a new type of cell culture dish was examined by studying the behavior of HeLa cells cultured on the sheets using light microscopy, scanning electron microscopy, and fluorescence microscopy observing actin and vinculin molecules. The nanopillar structure enabled easy subculture of the cells from the sheets without conventional trypsinization. Moreover, the HeLa cells divided and proliferated on the sheets in a different way to that found on petri dish because of the manner in which the cells adhered to the materials.
Journal of Orthopaedic Research | 2009
Shinsuke Sakai; Hajime Mishima; Tomoo Ishii; Hiroshi Akaogi; Tomokazu Yoshioka; Yoshimi Ohyabu; Fei Chang; Naoyuki Ochiai; Toshimasa Uemura
The method of constructing cartilage tissue from bone marrow‐derived cells in vitro is considered a valuable technique for hyaline cartilage regenerative medicine. Using a rotating wall vessel (RWV) bioreactor developed in a NASA space experiment, we attempted to efficiently construct hyaline cartilage tissue from human bone marrow‐derived cells without using a scaffold. Bone marrow aspirates were obtained from the iliac crest of nine patients during orthopedic operation. After their proliferation in monolayer culture, the adherent cells were cultured in the RWV bioreactor with chondrogenic medium for 2 weeks. Cells from the same source were cultured in pellet culture as controls. Histological and immunohistological evaluations (collagen type I and II) and quantification of glycosaminoglycan were performed on formed tissues and compared. The engineered constructs obtained using the RWV bioreactor showed strong features of hyaline cartilage in terms of their morphology as determined by histological and immunohistological evaluations. The glycosaminoglycan contents per µg DNA of the tissues were 10.01 ± 3.49 µg/µg DNA in the case of the RWV bioreactor and 6.27 ± 3.41 µg/µg DNA in the case of the pellet culture, and their difference was significant. The RWV bioreactor could provide an excellent environment for three‐dimensional cartilage tissue architecture that can promote the chondrogenic differentiation of adult human bone marrow‐derived cells.
Human Gene Therapy | 2008
Yoshimi Ohyabu; Zeenia Kaul; Tomokazu Yoshioka; Kazuki Inoue; Shinsuke Sakai; Hajime Mishima; Toshimasa Uemura; Sunil C. Kaul; Renu Wadhwa
Progress in stem cell research has prioritized the refinement of cell-labeling techniques for in vitro and in vivo basic and therapeutic studies. Although quantum dots, because of their optical properties, are emerging as favorable nanoparticles for bioimaging, substantial refinements or modifications that would improve their biocompatibility are still required. We report here that internalizing quantum dots (i-QDs) generated by their conjugation with an internalizing antibody against a heat shock protein-70 family stress chaperone, mortalin, offered an efficient, genetically noninvasive, nontoxic, and functionally inert way to label mesenchymal stem cells (MSCs). The i-QD-labeled MSCs underwent normal adipocyte, osteocyte, and chondrocyte differentiation in vitro and in vivo, suggesting the potential application of i-QDs in in vivo diagnostics, regenerative and therapeutic medicine.
Journal of Tissue Engineering and Regenerative Medicine | 2011
Tomokazu Yoshioka; Hajime Mishima; Zeenia Kaul; Yoshimi Ohyabu; Shinsuke Sakai; Naoyuki Ochiai; Sunil C. Kaul; Renu Wadhwa; Toshimasa Uemura
The purpose of this study was to track mesenchymal stem cells (MSCs) labelled with internalizing quantum dots (i‐QDs) in the reparative tissues, following the allogeneic transplantation of three‐dimensional (3D) cartilaginous aggregates into the osteochondral defects of rabbits. QDs were conjugated with a unique internalizing antibody against a heat shock protein‐70 (hsp70) family stress chaperone, mortalin, which is upregulated and expressed on the surface of dividing cells. The i‐QDs were added to the culture medium for 24 h. Scaffold‐free cartilaginous aggregates formed from i‐QD‐labelled MSCs (i‐MSCs), using a 3D culture system with chondrogenic supplements for 1 week, were transplanted into osteochondral defects of rabbits. At 4, 8 and 26 weeks after the transplantation, the reparative tissues were evaluated macroscopically, histologically and fluoroscopically. At as early as 4 weeks, the defects were covered with a white tissue resembling articular cartilage. In histological appearance, the reparative tissues resembled hyaline cartilage on safranin‐O staining throughout the 26 weeks. In the deeper portion, subchondral bone and bone marrow were well remodelled. On fluoroscopic evaluation, QDs were tracked mainly in bone marrow stromata, with some signals detected in cartilage and the subchondral bone layer. We showed that the labelling of rabbit MSCs with anti‐mortalin antibody‐conjugated i‐QDs is a tolerable procedure and provides a stable fluorescence signal during the cartilage repair process for up to 26 weeks after transplantation. The results suggest that i‐MSCs did not inhibit, and indeed contributed to, the regeneration of osteochondral defects. Copyright
Biotechnology and Bioengineering | 2006
Yoshimi Ohyabu; Naoko Kida; Hiroko Kojima; Tetsushi Taguchi; Junzo Tanaka; Toshimasa Uemura
Journal of Orthopaedic Research | 2007
Tomokazu Yoshioka; Hajime Mishima; Yoshimi Ohyabu; Shinsuke Sakai; Hiroshi Akaogi; Tomoo Ishii; Hiroko Kojima; Junzo Tanaka; Naoyuki Ochiai; Toshimasa Uemura
Archive | 2006
Junzo Tanaka; Yoshito Ikada; Yoshimi Ohyabu; Toshimasa Uemura
Archive | 2016
淑美 大藪; Yoshimi Ohyabu; 俊二 柚木; Shunji Yunoki; 博哉 畑山; Hirosuke Hatakeyama; 昌孝 井田; Masataka Ida; 陽介 平岡; Yosuke Hiraoka
Collaboration
Dive into the Yoshimi Ohyabu's collaboration.
National Institute of Advanced Industrial Science and Technology
View shared research outputsNational Institute of Advanced Industrial Science and Technology
View shared research outputsNational Institute of Advanced Industrial Science and Technology
View shared research outputsNational Institute of Advanced Industrial Science and Technology
View shared research outputs